Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Behrendt

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Frontiers in Microbiology|April 12, 2018
Environmental Stability and Infectivity of Hepatitis C Virus (HCV) in Different Human Body FluidsStephanie Pfaender, Fabian A Helfritz, Anindya Siddharta, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2017
Hepatitis E virus ORF 1 induces proliferative and functional T-cell responses in patients with ongoing and resolved hepatitis EJana Al-Ayoubi, Patrick Behrendt, Birgit Bremer, et al.
Joint Bone Spine|November 13, 2016
Exacerbation of hepatitis E virus infection during anti-TNFα treatmentPatrick Behrendt, Stefan Lüth, Werner Dammermann, et al.
Scientific Reports|March 29, 2025
Therapeutic treatment of hepatitis E virus infection in pigs with a neutralizing monoclonal antibodyIsabella Hrabal, Elmira Aliabadi, Sven Reiche, et al.
Hepatology (Baltimore, Md.)|April 29, 2014
Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particlesJuliane Doerrbecker, Martina Friesland, Nina Riebesehl, et al.
Journal of Hepatology|April 26, 2017
Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivityDorothea Bankwitz, Mandy Doepke, Kathrin Hueging, et al.
Intervirology|December 2, 2015
Hepatitis E Virus Seroprevalence Rate in HIV-Infected Patients in Germany: A Comparison of Two Commercial AssaysSven Pischke, Carolynne Schwarze-Zander, Birgit Bremer, et al.
JHEP Reports : Innovation in Hepatology|March 4, 2024
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatmentAndré Gömer, Katja Dinkelborg, Mara Klöhn, et al.
Antiviral Research|July 24, 2018
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivoDaniel Todt, Nora Moeller, Dimas Praditya, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2026
Acute HEV Infection Is a Relevant Cause of Decompensation and ACLF in Patients With Liver CirrhosisKatja Dinkelborg, Christian Niehaus, Birgit Bremer, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Frontiers in Microbiology|April 12, 2018
Environmental Stability and Infectivity of Hepatitis C Virus (HCV) in Different Human Body FluidsStephanie Pfaender, Fabian A Helfritz, Anindya Siddharta, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 19, 2017
Hepatitis E virus ORF 1 induces proliferative and functional T-cell responses in patients with ongoing and resolved hepatitis EJana Al-Ayoubi, Patrick Behrendt, Birgit Bremer, et al.
Joint Bone Spine|November 13, 2016
Exacerbation of hepatitis E virus infection during anti-TNFα treatmentPatrick Behrendt, Stefan Lüth, Werner Dammermann, et al.
Scientific Reports|March 29, 2025
Therapeutic treatment of hepatitis E virus infection in pigs with a neutralizing monoclonal antibodyIsabella Hrabal, Elmira Aliabadi, Sven Reiche, et al.
Hepatology (Baltimore, Md.)|April 29, 2014
Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particlesJuliane Doerrbecker, Martina Friesland, Nina Riebesehl, et al.
Journal of Hepatology|April 26, 2017
Maturation of secreted HCV particles by incorporation of secreted ApoE protects from antibodies by enhancing infectivityDorothea Bankwitz, Mandy Doepke, Kathrin Hueging, et al.
Intervirology|December 2, 2015
Hepatitis E Virus Seroprevalence Rate in HIV-Infected Patients in Germany: A Comparison of Two Commercial AssaysSven Pischke, Carolynne Schwarze-Zander, Birgit Bremer, et al.
JHEP Reports : Innovation in Hepatology|March 4, 2024
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatmentAndré Gömer, Katja Dinkelborg, Mara Klöhn, et al.
Antiviral Research|July 24, 2018
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivoDaniel Todt, Nora Moeller, Dimas Praditya, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2026
Acute HEV Infection Is a Relevant Cause of Decompensation and ACLF in Patients With Liver CirrhosisKatja Dinkelborg, Christian Niehaus, Birgit Bremer, et al.
Pageof 7